Wikipedia -WSS

Wikipedia

author：Wikipedia 2025-08-23 08:54:57 - browse：8

Drugmakers already bet big on mRNA for cancer. Now President Biden is going in, too? Anna Moneymaker/Getty Images

WASHINGTON — President Biden’s fledgling health agency, designed to accelerate under-funded research, just set its sights on one of the hottest areas of medicine — and one where the drug industry has a multibillion-dollar head start.

The White House announced Wednesday that the Advanced Research Projects Agency for Health would bankroll a $24 million project by Emory University to build messenger RNA platforms to target “cancer and other diseases,” investing in the technology behind the U.S.’s most commonly used vaccines for Covid-19.

The administration touted the news of CUREIT as the latest in Biden’s longtime mission to rein in cancer deaths, the Cancer Moonshot. But by using mRNA to treat cancer, ARPA-H is wading into a field that has advanced in fits and starts — and whose industry leaders have already spent multiples of the program’s entire budget into their own research. Moderna and BioNTech, massively profitable companies that have sold more than $80 billion worth of Covid-19 vaccines combined, have singled out oncology as the next big application for mRNA and invested accordingly.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： IVF, abortion rights issues kick off Biden’s State of the Union

WSS

Travis Kelce and the trap of celebrity vaccine endorsements

Readout Newsletter: Amylyx, Alto Neuro, and Eli Lilly for the Oscars

Novo Nordisk obesity pill bests Wegovy in early trial

Lung cancer screening guidelines updated for cigarette smokers

The health care issue Democrats can’t solve: hospital reform

Sen. Paul opposes bill to ban Chinese biotechs

hotspot

Wikipedia

hotspot

Hollywood unions extend contract negotiations for actors

Life sciences investors close nearly $6 billion in new funds

After affirmative action ruling, medical educators look to 'holistic review'

Readout Newsletter: Medeor's stem cell study, Moderna's stock dip

Drug repurposing or repositioning? The language matters

Bill would allow buprenorphine prescription for addiction via telehealth

Dobbs anniversary: the lost opportunity of abortion as health care

Readout LOUD podcast: The Sarepta saga, decoding biotech hype

ChatGPT in medicine: STAT answers readers' burning questions

Headspace, Meta partner to launch VR meditation app for Quest

explore

Infant mortality in U.S. rose last year for first time in decades: CDC

The problem with charging patients to message their doctors

How neuroscience research could help beat back brain cancer

Sen. Paul opposes bill to ban Chinese biotechs

Air quality improving but still lags in Black, Hispanic communities

Readout Newsletter: Acadia, Eli Lilly, Madrigal Pharma updates

focus

hotspot

knowledge

entertainment